Literature DB >> 22820434

Novel alpha-galactosidase A mutation in a female with recurrent strokes.

Antonino Tuttolomondo1, Giovanni Duro, Salvatore Miceli, Domenico Di Raimondo, Rosaria Pecoraro, Antonia Serio, Giuseppe Albeggiani, Domenico Nuzzo, Francesco Iemolo, Federica Pizzo, Serafina Sciarrino, Giuseppe Licata, Antonio Pinto.   

Abstract

Anderson-Fabry disease (AFD) is an X-linked inborn error of glycosphingolipid catabolism resulting from the deficient activity of the lysosomal exoglycohydrolase, a-galactosidase A. The complete genomic and cDNA sequences of the human alpha-galactosidase A gene have been determined and to date, several disease-causing alpha-galactosidase A mutations have been identified, including missense mutations, small deletions/insertions, splice mutations, and large gene rearrangements We report a case of a 56-year-old woman with recurrent cryptogenic strokes. Ophthalmological examination revealed whorled opacities of the cornea (cornea verticillata) and dilated tortuous conjunctival vessels. She did not show other typical signs of Fabry disease such as acroparesthesias and angiokeratoma. The patient's alpha-galactosidase A activity was 4.13 nmol/mL/h in whole blood. Alpha-galactosidase A gene sequence analysis revealed a heterozygous single nucleotide point mutation at nucleotide c.550T>A in exon 4 in this woman, leading to the p.Tyr184Asn amino acid substitution.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820434     DOI: 10.1016/j.clinbiochem.2012.07.085

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  De novo mutation in a male patient with Fabry disease: a case report.

Authors:  Francesco Iemolo; Federica Pizzo; Giuseppe Albeggiani; Carmela Zizzo; Paolo Colomba; Simone Scalia; Caterina Bartolotta; Giovanni Duro
Journal:  BMC Res Notes       Date:  2014-01-07

2.  Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report.

Authors:  Yosep Chong; Minyoung Kim; Eun Sil Koh; Seok Joon Shin; Ho-Shik Kim; Sungjin Chung
Journal:  BMC Med Genet       Date:  2016-10-24       Impact factor: 2.103

Review 3.  Identification of a Missense Mutation in the α-galactosidase A Gene in a Chinese Family with Fabry Disease.

Authors:  Yuan Wu; Hong Xia; Jinzhong Yuan; Hongbo Xu; Xiong Deng; Jun Liu; Hao Zhang; Hao Deng
Journal:  Curr Genomics       Date:  2018-01       Impact factor: 2.236

4.  Genotype⁻Phenotype Correlation in a New Fabry-Disease-Causing Mutation.

Authors:  Agnė Čerkauskaitė; Rimantė Čerkauskienė; Marius Miglinas; Arvydas Laurinavičius; Can Ding; Arndt Rolfs; Lina Vencevičienė; Jūratė Barysienė; Edita Kazėnaitė; Eglė Sadauskienė
Journal:  Medicina (Kaunas)       Date:  2019-05-07       Impact factor: 2.430

5.  Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease.

Authors:  Antonino Tuttolomondo; Irene Simonetta; Giovanni Duro; Rosaria Pecoraro; Salvatore Miceli; Paolo Colomba; Carmela Zizzo; Antonia Nucera; Mario Daidone; Tiziana Di Chiara; Rosario Scaglione; Vittoriano Della Corte; Francesca Corpora; Danai Vogiatzis; Antonio Pinto
Journal:  Oncotarget       Date:  2017-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.